Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to dist ...

Early-life mutagenic exposure to colibactin-producing bacteria may be associated with the increased incidence of early-onset colorectal cancer.

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

Among patients with acute LBP, use of nonpharmacologic therapy was associated with reduced risk for overdose-related hospitalizations.

Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD).

Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Patients with at least 5 comorbidities had worsened pain and functional scores compared with patients with 3 comorbidities at 12 months following TKA.

Hospital-onset antimicrobial-resistant infections increased across US hospitals during and beyond the COVID-19 pandemic.

Patients with vs without RA have a higher risk for avoidable hospitalizations for ambulatory care sensitive conditions, particularly heart failure and pulmonary edema.

Ultrasound-guided minimally invasive tenosynovial biopsy is a feasible, safe, and well-tolerated technique among patients with different stages of RA.